Japan Cell and Gene Therapy Market Growth, Size, Trends Analysis- By Therapy Type, By Indication, By Delivery Mode, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Japan Cell and Gene Therapy Market Growth, Size, Trends Analysis- By Therapy Type, By Indication, By Delivery Mode, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Japan Cell and Gene Therapy Market Introduction and Overview

According to SPER Market Research, ‘Japan Cell and Gene Therapy Market Size- By Therapy Type, By Indication, By Delivery Mode, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Japan Cell and Gene Therapy Market is estimated to reach USD 9744.68 million by 2033 with a CAGR of 12.71%.

Cell and gene therapy are cutting-edge medical treatments with immense promise for treating a wide range of diseases and maladies. In essence, cell therapy is the transplantation or manipulation of living cells to replace or repair damaged or dysfunctional tissues in the human body. This may include using stem cells to restore damaged organs or tissues. On the other hand, gene therapy focuses on modifying or correcting faulty genes that cause disease.

COVID-19 Impact on Japan Cell and Gene Therapy Market

The COVID-19 pandemic has had a substantial influence on the cell and gene therapy manufacturing sector.

Accelerated Research and Development - The pandemic has spurred research and development of cell and gene treatments, which have the potential to treat COVID-19 and related problems.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Therapy Type, By Indication, By Delivery Mode, By End User
Regions covered Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region.
Companies Covered Bristol-Myers Squibb Company, 2seventy bio, Inc, Novartis AG, Gilead Sciences Inc (Kite Pharma), Spark Therapeutics, Inc, Nipro Corporation, JCR Pharmaceuticals Co., Ltd, Aurion Biotech, Johnson & Johnson Services, Inc, Terumo BCT.

Japan Cell and Gene Therapy Market Segmentation:

By Therapy Type: Based on the Therapy Type, Japan Cell and Gene Therapy Market is segmented as; Cell Therapy, Gene Therapy.

By Indication: Based on the Indication, Japan Cell and Gene Therapy Market is segmented as; Cardiovascular Disease, Oncology Disorder, Genetic Disorder, Infectious Disease, Neurological Disorder, and Others.

By Delivery Mode: Based on the Delivery Mode, Japan Cell and Gene Therapy Market is segmented as; In-Vivo, Ex-Vivo.

By End User: Based on the End User, Japan Cell and Gene Therapy Market is segmented as; Hospitals, Cancer Care Centers, Pharmaceutical and Biotechnology Companies, and Others.